Keep up with personal finance and investing trends. Stock Market, Mutual Funds, Insurance, and lot more.
All that you should know about the Company before applying for the IPO.
The public issue of equity shares of TARSONS PRODUCTS LIMITED will open for subscription on November 15, 2021 and closes on November 17, 2021. It is expected to list on the stock exchanges on November 26, 2021. What does the company do? Why is the company going public? Who are its key competitors? Its key strengths, and lot more. Here’s everything that you want to know about the company to analysis the IPO.
The company is a leading Indian life sciences company with more than three decades of experience in the production and supply of labware products. It manufactures a range of quality labware products that helps advance scientific discovery and improve healthcare systems. Its product portfolio is classified into three broad categories including consumables, reusables, and others. It also has a diversified product portfolio with over 1,700 SKUs across 300 products.
Trason's products are used in various laboratories across research organizations, academic institutes, pharmaceutical companies, Contract Research Organizations (CRO), diagnostic companies, and hospitals. The company has many reputed institutes, medical labs, and hospitals as its key clients.
Currently, the company has 5 manufacturing facilities. It has a strong distribution network across India comprising of over 141 authorized distributors and supplies its products to more than 40 countries.
Sanjive Sehgal and Rohan Sehgal
No listed peers in India.
Given below are the objectives of the Company –
The Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:
The Offer comprises a Fresh Issue by the company and an Offer for Sale by the selling shareholders. The company will not receive any proceeds from the Offer for Sale.
IPO Size | ₹ 1023.84Crore* |
---|---|
Offer Mix | Fresh Issue ₹ 150 Crore + Offer For Sale ₹ 873.84 Crore |
Price Band | ₹ 635 - ₹ 662 |
Lot Size | 22 Shares (& in multiples thereof) |
Face Value | ₹ 2 |
Application Amount | Min. ₹ 14564 (1 lot) | Max. ₹ 189332 (13 lots) [at upper price band] |
Listing on | NSE & BSE |
Registrar | KFin Technologies Private Limited |
Cut-off time for UPI Mandate Confirmation | 18-Nov-2021 (up to 12:00 PM) |
QIB | ₹ 509.94 Crore (50% of Net Issue Size) |
---|---|
NIB | ₹ 152.98 Crore (15% of Net Issue Size) |
Retail | ₹ 356.95 Crore (35% of Net Issue Size) |
Employee Reservation Portion | ₹ 3.97 Crore (60,000 Equity Shares) |
Activity | Date |
---|---|
IPO Opens | November 15, 2021 |
IPO Closes | November 17, 2021 |
Finalization of the basis of allotment | November 23, 2021 |
Unblocking of funds / Initiation of refunds | November 24, 2021 |
Credit of equity shares to Demat accounts | November 25, 2021 |
Listing of equity shares | November 26, 2021 |
Apply online in just 5 minutes!
Apply Now Investment in securities market is subject to market risks, read all the related documents carefully before investing.Wealthstreet is one-stop solution for all your financial requirements.
© 2021 Wealthstreet Financial Services Private Limited. All Right Reserved.
Wealthstreet refers to Wealthstreet Financial Services Private Limited. Wealthstreet Financial Services Private Limited: INZ000157331 (Member of NSE, BSE and MCX). Wealthstreet Financial Services Private Limited acts in the capacity of a distributor for Mutual Funds having AMFI Registration Number – 118251.
Mutual Fund Investments are subject to market risks. Please read all scheme related documents carefully before investing. Investment in the securities involves risks. The user is required to undergo risk profiling before investing. Guided view is indicative in nature and is based on the information provided by the user voluntarily. Each user of this information should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred here (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such investment. Past performance is not necessarily a guide to future performance.
The information contained in this website is for general information purposes only. The information is provided by Accord Fintech Private Limited. While we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the timeliness, completeness, accuracy, reliability, suitability or availability with respect to the website or the information or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk. Wealthstreet Financial Services Private Limited shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this website.
Content Powered by Accord Fintech Pvt. Ltd.
Broking and DP services offered by Wealthstreet Financial Services Private Limited under SEBI Registration No.: INZ000157331 (Member of NSE, BSE and MCX) and IN-DP-CDSL-361-2018 (DP with CDSL). Investor grievance resolution team, Tel: 079-66775500, Email ID: grievance@wealthstreet.in. Name of the Compliance Officer for Trading & DP – Mr. Suren Pandya, Email ID: compliance@wealthstreet.in. Corporate Office: A – 1101, Mondeal Heights, S.G.Highway, Ahmedabad – 380015.; Tel. 079-66775500.
Link to SCORES portal – https://www.scores.gov.in/scores/Welcome.html